OrthogenRx, Inc. is a medical device company focused on the development and commercialization of treatments for musculoskeletal conditions including osteoarthritis (OA).
Location: United States, Pennsylvania, Doylestown Township
Total raised: $2.2M
Investors 2
| Date | Name | Website |
| - | Ben Frankl... | sep.benfra... |
| - | New Age Ve... | newagevent... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.05.2017 | Seed | $2.2M | - |
Mentions in press and media 3
| Date | Title | Description |
| 15.12.2021 | Avanos Medical To Acquire OrthogenRx for $160 Million | The purchase price consists of $130 million in cash at closing plus an additional $30 million in contingent cash consideration, payable upon the achievement of growth milestones related to the company’s commercial hyaluronic acid (HA) thera... |
| 07.10.2015 | GenVisc 850 Approved by the FDA for Treatment of Osteoarthritis Knee Pain – Disruptive medical device reducing healthcare cost | DOYLESTOWN, Pa.–(BUSINESS WIRE)–October 7, 2015– OrthogenRx Inc. has announced the US Food and Drug Administration (FDA) approval of GenVisc 850® (sodium hyaluronate) for the treatment of patients with osteoarthritis (OA) knee pain. GenVisc... |
| 11.12.2014 | Updated: Ben Franklin Approves $2.8M for Sixteen Early-Stage Companies |